Key insights
- An investor seeks advice on managing a highly profitable, concentrated LEAPS portfolio in AI/Memory stocks. The investor is weighing the benefits of holding for long-term capital gains against the risk of a sector correction and potential loss of gains. Strategies considered include holding, rolling strikes, trimming positions, or selling all and buying shares. The question revolves around balancing tax optimization with risk reduction.
Like alot of you investing in AI/Memory/my beloved Nebius, I had some rough months which turned into explosive growth recently. Most of the positions were opened around April lows and are now up anywhere from ~50% to over 300%.
My portfolio is exclusively LEAPS with expirations from 1/2028-6/2028
Most of the contracts currently have deltas around 0.7–0.9, so they behave almost like leveraged stock positions at this point if I understand that correctly
The dilemma- If I hold until next April, most positions would qualify for long-term capital gains treatment.
But I’m also aware that I’m sitting on a concentrated, high-beta portfolio after a massive run and could give back a lot if the sector corrects.
My choices-
1.Holding everything until LTCG treatment kicks in
2.Rolling strikes upward to reduce delta while maintaining exposure
3.Trimming some positions now and paying short-term gains
4.Trimming all positions, biting the tax bullet and buying share in order to lock in these gains and play the future a big safer
At what point does risk reduction become more important than optimizing taxes? Portfolio is right around 350k as of today. Thanks all!!